Ontology highlight
ABSTRACT: Background
Malabsorption of fat and protein contributes to poor nutritional status in people with cystic fibrosis. Impaired pancreatic function may also result in increased gastric acidity, leading in turn to heartburn, peptic ulcers and the impairment of oral pancreatic enzyme replacement therapy. The administration of gastric acid-reducing agents has been used as an adjunct to pancreatic enzyme therapy to improve absorption of fat and gastro-intestinal symptoms in people with cystic fibrosis. It is important to establish the evidence regarding potential benefits of drugs that reduce gastric acidity in people with cystic fibrosis. This is an update of a previously published review.Objectives
To assess the effect of drug therapies for reducing gastric acidity for: nutrition
SUBMITTER: Ng SM
PROVIDER: S-EPMC8079129 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature